Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexmedetomidine.

J Mantz1

  • 1Department of Anesthesiology and Critical Care, and Institut National de la Sante et de la Recherche Medicale (INSERM), Hospital Bichat, Paris, France.

Drugs of Today (Barcelona, Spain : 1998)
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micro-fragmented fat injection reduces sepsis-induced acute inflammatory response in a mouse model.

British journal of anaesthesia·2018
Same author

Mismatch negativity to predict subsequent awakening in deeply sedated critically ill patients.

British journal of anaesthesia·2018
Same author

Impact of sleep deprivation on anaesthesia residents' non-technical skills: a pilot simulation-based prospective randomized trial.

British journal of anaesthesia·2017
Same author

Risk factors of percutaneous cannulation failure by intensivists for veno-arterial extracorporeal life support for refractory cardiac arrest.

Intensive care medicine·2017
Same author

Selective primary outcome reporting in high-impact journals of anaesthesia and pain.

British journal of anaesthesia·2017
Same author

Pilot study of closed-loop anaesthesia for liver transplantation.

British journal of anaesthesia·2016

Dexmedetomidine, an alpha(2)-adrenoceptor agonist, effectively reduces sympathetic activity, lowering heart rate and blood pressure. It offers cardiovascular stability, sedation, and pain relief with minimal respiratory effects, making it valuable in perioperative and critical care settings.

Area of Science:

  • Pharmacology
  • Anesthesiology
  • Critical Care Medicine

Background:

  • Sympathetic tone modulation is key for managing stress-induced hemodynamic disorders.
  • Alpha(2)-adrenoceptor agonists, like dexmedetomidine, reduce sympathetic activity by inhibiting norepinephrine release.
  • Dexmedetomidine is a potent and selective alpha(2)-adrenoceptor agonist with known cardiovascular effects.

Purpose of the Study:

  • To review the pharmacological properties and clinical applications of dexmedetomidine.
  • To highlight its benefits in perioperative cardiovascular stability and sedation.
  • To discuss the role of the alpha(2A) subtype in its observed effects.

Main Methods:

  • Review of existing scientific literature on dexmedetomidine.
  • Analysis of studies detailing its effects on hemodynamics, sympathetic activity, and receptor subtypes.

Related Experiment Videos

  • Examination of clinical data regarding its perioperative and critical care use.

    • Main Results:

    • Dexmedetomidine decreases heart rate and blood pressure in both animal and human studies.
    • It enhances perioperative cardiovascular stability and reduces ischemic episodes in coronary artery disease patients.
    • The alpha(2A) receptor subtype is implicated in dexmedetomidine's sedative and anesthetic-sparing effects.

    Conclusions:

    • Dexmedetomidine exhibits significant cardiovascular, anxiolytic, sedative, anesthetic-sparing, and analgesic properties.
    • It demonstrates minimal respiratory depression, enhancing its safety profile.
    • Its unique properties make dexmedetomidine a valuable agent for perioperative management and critical care sedation.